Funds · KYTX

Who owns KYTX?

Institutional ownership of Kyverna Therapeutics Inc. from Form 13F, Q2 2026

120 institutional managers reported holding Kyverna Therapeutics Inc. (KYTX) in Form 13F filings for Q2 2026, with 37,594,332 shares worth $335M. The largest reported holder was GordonMD Global Investments LP. Managers that filed both quarters added a net 2,771,036 shares (+8.0%). 31 opened new positions and 21 sold out.

Funds holding
120
Value held
$335M
New / sold out
31 / 21
Net shares, same filers
+8.0%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of KYTX

FundValueShare of 13F holdingsSharesMove
GordonMD Global Investments LP$37.8M11.3%4,244,818Unchanged
Gilead Sciences, Inc.$36.8M11.0%4,126,119Unchanged
BlackRock, Inc.$27.9M8.3%3,134,807Added
Bain Capital Life Sciences Investors, LLC$25.7M7.7%2,885,000Trimmed
AIGH Capital Management LLC$24.9M7.4%2,795,797Added
Deerfield Management Company, L.p.$17.8M5.3%2,000,000Unchanged
Vanguard Capital Management LLC$16.9M5.0%1,897,451Added
Price T Rowe Associates Inc$10.6M3.2%1,186,023Trimmed
Geode Capital Management, LLC$9.4M2.8%1,049,430Added
Insight Holdings Group, LLC$8.8M2.6%989,054Unchanged
Morgan Stanley$8.8M2.6%982,307Added
State Street Corp$8.8M2.6%982,233Added
Propel Bio Management, LLC$7.9M2.3%883,198Added
Woodline Partners LP$7.5M2.2%845,325Unchanged
Millennium Management LLC$5.7M1.7%639,780Trimmed
MBB Public Markets I LLC$5.5M1.6%614,477Unchanged
Adage Capital Partners GP, L.l.c.$4.5M1.3%500,000Unchanged
D. E. Shaw & Co., Inc.$4.2M1.2%469,346Trimmed
Wells Fargo & Company$3.3M1.0%373,009Added
UBS Group AG$3.3M1.0%365,574Trimmed
Goldman Sachs Group Inc$3.0M0.9%335,230Added
Renaissance Technologies LLC$3.0M0.9%333,899Trimmed
Charles Schwab Investment Management Inc$2.8M0.9%319,666Added
Northern Trust Corp$2.8M0.8%315,354Added
BNP Paribas Financial Markets$2.8M0.8%310,632Trimmed

Share of 13F holdings is each fund's shares as a share of the 37,594,332 KYTX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $69.6M and sold $44.6M; 36 added and 28 trimmed.

Schedule 13D and 13G filings on KYTX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about KYTX ownership

Who owns KYTX stock?
120 institutional investment managers reported KYTX positions in their Form 13F filings for Q2 2026, holding 37,594,332 shares worth $335M in total. GordonMD Global Investments LP reported the largest position.
Are funds buying or selling KYTX?
In Q2 2026, 31 managers opened new KYTX positions, 36 added, 28 trimmed and 21 sold out. Managers that filed in both quarters added a net 2,771,036 shares.
How current is this KYTX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to KYTX by CUSIP. Options are left out. KYTX news and filings · KYTX insider trades · Top funds